These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7505423

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Placebo-controlled evaluation of Ritalin side effects.
    Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ.
    Pediatrics; 1993 Jun; 91(6):1101-6. PubMed ID: 8502509
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131
    [Abstract] [Full Text] [Related]

  • 26. Attention deficit disorder with hyperactivity: differential effects of methylphenidate on impulsivity.
    Rapport MD, DuPaul GJ, Stoner G, Birmingham BK, Masse G.
    Pediatrics; 1985 Dec 30; 76(6):938-43. PubMed ID: 4069863
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
    Biederman J, Gao H, Rogers AK, Spencer TJ.
    Biol Psychiatry; 2006 Nov 15; 60(10):1106-10. PubMed ID: 16806096
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effectiveness of iron supplementation in a young child with attention-deficit/hyperactivity disorder.
    Konofal E, Cortese S, Lecendreux M, Arnulf I, Mouren MC.
    Pediatrics; 2005 Nov 15; 116(5):e732-4. PubMed ID: 16263988
    [Abstract] [Full Text] [Related]

  • 35. The relationship between vigilance deficits and traffic injuries involving children.
    Pless IB, Taylor HG, Arsenault L.
    Pediatrics; 1995 Feb 15; 95(2):219-24. PubMed ID: 7838639
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of hyperactive children with D-phenylalanine.
    Zametkin AJ, Karoum F, Rapoport JL.
    Am J Psychiatry; 1987 Jun 15; 144(6):792-4. PubMed ID: 3296793
    [Abstract] [Full Text] [Related]

  • 40. Use of aspartame by apparently healthy children and adolescents.
    Frey GH.
    J Toxicol Environ Health; 1976 Nov 15; 2(2):401-15. PubMed ID: 137987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.